Tag: Drug Approvals
FDA Approves Expanded Use for Melanoma Drug
Yervoy can now be used after surgery to reduce risk of skin cancer returning
FDA Approves Imlygic for Melanoma
Injectable drug designed to rupture and kill cancer cells
FDA Approves Onivyde for Metastatic Pancreatic Cancer
To be used in combination with fluorouracil/leucovorin for advanced disease
FDA Approves Yondelis for Soft-Tissue Sarcoma
Drug sanctioned for liposarcoma or leiomyosarcoma
FDA Approves Coagadex for Rare Clotting Disorder
First coagulation therapy sanctioned for Factor X deficiency
FDA Approves Praxbind to Reverse Pradaxa’s Effect
Praxbind cleared for emergency use with Pradaxa when bleeding can't be controlled
FDA Approves Optune Device for Newly Diagnosed Glioblastoma
Newly sanctioned to treat just-diagnosed patients, in combination with temozolomide
FDA OKs Long-Acting Atypical Antipsychotic for Schizophrenia
Aristada (aripiprazole lauroxil) is injected every four-to-six weeks
FDA Approves Keytruda for Advanced NSCLC
Approved for use with PD-L1 IHC 22C3 pharmDx test
FDA Approves Lonsurf for Metastatic Colorectal Cancer
For patients with metastatic CRC previously treated with chemotherapy, biological therapy
